Guardian Pharmacy Services (GRDN) Cost of Revenue (2023 - 2026)

Guardian Pharmacy Services' Cost of Revenue history runs 4 years deep, the most recent figure standing at $260.3 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 1.76% year-over-year to $260.3 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 11.92% YoY), while the FY2025 annual figure was $1.2 billion, up 17.47% from the prior year.
• Cost of Revenue came in at $260.3 million for Q1 2026 at Guardian Pharmacy Services, down from $312.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $312.1 million in Q4 2025 to a low of $210.5 million in Q3 2023.
• A 4-year average of $257.9 million and a median of $260.3 million in 2026 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue climbed 20.41% in 2024 and fell 1.76% in 2026, its largest moves.
• Guardian Pharmacy Services' Cost of Revenue stood at $226.5 million in 2023, then advanced by 19.86% to $271.5 million in 2024, then grew by 14.97% to $312.1 million in 2025, then decreased by 16.61% to $260.3 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $260.3 million, $312.1 million, and $302.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison